Marijo Bilusic, M.D., Ph.D., a boardcertified medical oncologist who treats genitourinary tumors, has joine Sylvester as leader of the Genitourinary Cancers Site Disease Group.

Dr. Bilusic’s current research interests focus on tumor immunology and development of novel immunotherapy approaches for genitourinary and other tumors using therapeutic cancer vaccines, antibodies, or immune modulators. He earned his medical degree at the University of Zagreb School of Medicine in Croatia and completed his Ph.D. training at the University of Split School of Medicine in Croatia. In addition, he completed a postdoctoral research fellowship in physiological genomics at the Medical College of Wisconsin’s Human and Molecular Genetics Center in Milwaukee.

In 2017, Dr. Bilusic received the NIH Director’s Award as a member of the NIH Hematology Oncology Fellowship Team, for extraordinary resourcefulness and initiative. His passion for teaching and mentoring has earned multiple awards at NIH and NCI. He is board certified in medical oncology, hematology, and internal medicine.